BIO-RAD LABS INC. B DL 1 (BUW F) stock market data APIs
€229.9841
0(0%)
as of December 5, 2025
Try our APIs with
free plan!
BIO-RAD LABS INC. B DL 1 Financial Data Overview
Price chart is built with
Anychart
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials, such as cells, proteins, and nucleic acids used in biopharmaceutical manufacturing, quality control process, food safety, and science education applications. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, and transfusion and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Prev. Close
229.9841
Open
229.9841
High
229.9841
Low
229.9841
52 wk Range
206-332
Market Cap
8 333 M
Shares Outstanding
5 068 K
Revenue
2 557 M
Beta
1.187
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get BIO-RAD LABS INC. B DL 1 data using free add-ons & libraries
Get BIO-RAD LABS INC. B DL 1 Fundamental Data
BIO-RAD LABS INC. B DL 1 Fundamental data includes:
- Net Revenue: 2 557 M
- EBITDA: 418 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
BIO-RAD LABS INC. B DL 1 News
New
A Look At The Intrinsic Value Of Bio-Rad Laboratories, Inc. (NYSE:BIO)
Key Insights The projected fair value for Bio-Rad Laboratories is US$394 based on 2 Stage Free Cash Flow to Equity With US$325 share price, Bio-Rad Laboratories appears to be trading close to its est...
Autoimmune Disease Diagnostics Market Competitive Landscape Report 2025: Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and Revenue Forecasts
Company Logo The Autoimmune Disease Diagnostics industry is set for significant growth, projected to leap from US$ 5.70 billion in 2024 to US$ 10.63 billion by 2033, at a CAGR of 7.17%. Key growth dr...
HbA1c Testing Market Research Report 2025-2033, Profiles of Key Players - Danaher, F. Hoffmann-La Roche, Siemens, Abbott, Bio-Rad Laboratories, ARKRAY, Trinity Biotech, EKF Diagnostics
Company Logo The HbA1c testing market presents opportunities driven by rising Type 2 diabetes cases and advancements in testing technologies. Supportive healthcare initiatives and increased awareness...
Is Bio-Rad’s Earnings Miss and Biodesix Partnership Redefining the Investment Outlook for BIO?
On October 29, 2025, Bio-Rad Laboratories reported third-quarter earnings with sales of US$653 million and a net loss of US$341.9 million, while also completing a major share repurchase and announcing...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
